134 related articles for article (PubMed ID: 25301988)
1. An
Giustini AJ; Ivkov R; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810M. PubMed ID: 25301988
[TBL] [Abstract][Full Text] [Related]
2. Magnetic nanoparticle biodistribution following intratumoral administration.
Giustini AJ; Ivkov R; Hoopes PJ
Nanotechnology; 2011 Aug; 22(34):345101. PubMed ID: 21795772
[TBL] [Abstract][Full Text] [Related]
3. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment.
Petryk A; Giustini A; Ryan P; Strawbridge R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810N. PubMed ID: 25346581
[TBL] [Abstract][Full Text] [Related]
4. Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells.
Hoopes P; Tate J; Ogden J; Strawbridge R; Fiering S; Petryk A; Cassim S; Giustini A; Demidenko E; Ivkov R; Barry S; Chinn P; Foreman A
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810P. PubMed ID: 25346583
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral Iron Oxide Nanoparticle Hyperthermia and Radiation Cancer Treatment.
Hoopes P; Strawbridge R; Gibson U; Zeng Q; Pierce Z; Savellano M; Tate J; Ogden J; Baker I; Ivkov R; Foreman A
Proc SPIE Int Soc Opt Eng; 2007 Feb; 6440():64400K. PubMed ID: 25301985
[TBL] [Abstract][Full Text] [Related]
6. Iron Oxide Hyperthermia And Radiation Cancer Treatment.
Cassim S; Giustini A; Petryk A; Strawbridge R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810O. PubMed ID: 25346582
[TBL] [Abstract][Full Text] [Related]
7. Iron oxide nanoparticle enhancement of radiation cytotoxicity.
Mazur CM; A Tate J; Strawbridge RR; Gladstone DJ; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():85840J. PubMed ID: 25301998
[TBL] [Abstract][Full Text] [Related]
8. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
Dan M; Bae Y; Pittman TA; Yokel RA
Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
[TBL] [Abstract][Full Text] [Related]
9. Comparison of iron oxide nanoparticle and microwave hyperthermia alone or combined with cisplatinum in murine breast tumors.
Petryk AA; Stigliano RV; Giustini AJ; Gottesman RE; Trembly BS; Kaufman PA; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2011 Feb; 7901():. PubMed ID: 24386533
[TBL] [Abstract][Full Text] [Related]
10. Kinetics and pathogenesis of intracellular magnetic nanoparticle cytotoxicity.
Giustini AJ; Gottesman RE; Petryk AA; Rauwerdink AM; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2011 Feb; 7901():. PubMed ID: 24382988
[TBL] [Abstract][Full Text] [Related]
11. Characterization of intratumor magnetic nanoparticle distribution and heating in a rat model of metastatic spine disease.
Zadnik PL; Molina CA; Sarabia-Estrada R; Groves ML; Wabler M; Mihalic J; McCarthy EF; Gokaslan ZL; Ivkov R; Sciubba D
J Neurosurg Spine; 2014 Jun; 20(6):740-50. PubMed ID: 24702509
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Iron Oxide Nanoparticle and Waterbath Hyperthermia Cytotoxicity.
Ogden J; Tate J; Strawbridge R; Ivkov R; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810K. PubMed ID: 25301987
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications.
Kruse AM; Meenach SA; Anderson KW; Hilt JZ
Acta Biomater; 2014 Jun; 10(6):2622-9. PubMed ID: 24486913
[TBL] [Abstract][Full Text] [Related]
14. Comparison of microwave and magnetic nanoparticle hyperthermia radiosensitization in murine breast tumors.
Giustini AJ; Petryk AA; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2011 Feb; 7901():. PubMed ID: 24392200
[TBL] [Abstract][Full Text] [Related]
15. Targeting of systemically-delivered magnetic nanoparticle hyperthermia using a noninvasive, static, external magnetic field.
Zulauf GD; Trembly BS; Giustini AJ; Flint BR; Strawbridge RR; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():85840C. PubMed ID: 24073325
[TBL] [Abstract][Full Text] [Related]
16. Dextran-Coated Iron Oxide Nanoparticles Loaded with 5-Fluorouracil for Drug-Delivery Applications.
Predoi D; Balas M; Badea MA; Ciobanu SC; Buton N; Dinischiotu A
Nanomaterials (Basel); 2023 Jun; 13(12):. PubMed ID: 37368241
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines.
Zhu XM; Wang YX; Leung KC; Lee SF; Zhao F; Wang DW; Lai JM; Wan C; Cheng CH; Ahuja AT
Int J Nanomedicine; 2012; 7():953-64. PubMed ID: 22393292
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of antibody-targeted and non-targeted iron oxide nanoparticles in a breast cancer mouse model.
Tate JA; Kett W; NDong C; Griswold KE; Hoopes PJ
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8584():85840G. PubMed ID: 25301995
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Imaging and Quantification of Iron Oxide Nanoparticle Uptake and Biodistribution.
Hoopes PJ; Petryk AA; Gimi B; Giustini AJ; Weaver JB; Bischof J; Chamberlain R; Garwood M
Proc SPIE Int Soc Opt Eng; 2012 Mar; 8317():. PubMed ID: 25285189
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and Biodistribution of Activated and Non-activated Intravenous Iron Oxide Nanoparticles.
Tate J; Ogden J; Strawbridge R; Pierce Z; Hoopes P
Proc SPIE Int Soc Opt Eng; 2009 Feb; 7181():71810L. PubMed ID: 25300674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
